The Prostatic Acid Phosphatase Test detects PAP, an enzyme produced in the prostate, to provide information about prostate health and possible disease. Abnormal levels may suggest prostate cancer, metastatic spread, or benign prostate conditions. This test supports assessment of prostate function, systemic effects, and urologic health, offering insight into disease monitoring and progression.

The PSA Total Test with 2.5 ng/mL Cutoff measures prostate-specific antigen in blood to screen for prostate cancer and evaluate prostate health. A result above 2.5 ng/mL may indicate increased cancer risk or benign conditions like prostatitis or BPH. Doctors order this test for men with urinary symptoms or as part of routine screening. Results help detect cancer earlier, monitor prostate conditions, and guide decisions on further evaluation or treatment.

The PSA Free and Total Test measures prostate-specific antigen in blood, reporting both free and total PSA to help evaluate prostate health. It is used to screen for prostate cancer, differentiate between cancer and benign conditions like prostatitis or enlarged prostate (BPH), and monitor treatment. Doctors order this test for men with urinary symptoms or at risk of prostate disease. Results provide key insight into prostate function and overall men’s health.

The Post-Prostatectomy PSA Test measures prostate-specific antigen levels in blood after surgical removal of the prostate. PSA should drop to very low or undetectable levels following surgery. Rising or persistent PSA may indicate recurrence of prostate cancer. Doctors use this test to closely monitor recovery, detect early signs of cancer return, and guide further treatment decisions, making it an essential tool for long-term prostate cancer management.

The PSA Total and Testosterone Total Males Panel is a specialized set of blood tests tailored for men to evaluate prostate health and testosterone levels. This panel combines two crucial markers: the Prostate-Specific Antigen (PSA) and total testosterone levels, making it an essential tool for assessing men's health, particularly in the areas of reproductive health and prostate function.

The PSA Total Test measures prostate-specific antigen levels in blood to evaluate prostate health. Elevated PSA may indicate prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis. Doctors use this test for early detection of prostate cancer, monitoring treatment, or assessing recurrence risk. Commonly recommended for men over 50 or those at higher risk, the PSA test supports diagnosis, prevention, and long-term prostate care.

The PSA Post Prostatectomy Test with HAMA Treatment measures prostate-specific antigen (PSA) levels following prostate removal surgery. This test uses Heterophilic Antibody Blocking (HAMA) treatment to eliminate antibody interference, ensuring accurate detection of residual or recurrent prostate cancer and improving post-surgical monitoring precision.

 The Cancer Screening - Men panel is a comprehensive diagnostic tool designed to detect early signs of various cancers in men. This panel includes a series of tests that measure specific biomarkers associated with different types of cancer. By assessing these biomarkers, healthcare providers can identify the presence of cancer at an early stage, when treatment is often more effective. This panel is crucial for men who are at higher risk of developing cancer due to factors such as age, family history, or lifestyle.

The Testosterone Replacement Therapy (TRT) Panel is designed for individuals undergoing or considering TRT. It evaluates key health markers that are crucial for safely managing testosterone replacement therapy, focusing on blood health, testosterone levels, and prostate health.